Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
US 2023 NASS conference : VEOS System
Press release Ecully, Novembre 2, 2023 – 6:30 p.m. VEOS system well perceived at the NASS 2023 conferencein the United StatesSales growth in France Spineway Group, specialists in innovative implants for the treatment of severe spinal pathologies, is pleased to announce that its VEOS posterior spinal fixation system received an excellent response from the spine implant industry at the North American Spine Society (NASS) Congress in Los Angeles last October 1...
Nasdaq GlobeNewswire
02/11/2023
Number of voting rights as of October 31, 2023
Nicox SA Société anonyme with a registered capital of € 50,170,498 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On November 2, 2023, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l'AMF) As of October 31, 2023 Total number of shares...
Nasdaq GlobeNewswire
02/11/2023
VIRBAC: Virbac acquired a majority stake in Globion, a leading Indian poultry…
On November 1, we successfully finalized the acquisition of a majority stake in Globion. This transaction will bolster our position of animal health leader in India by extending Virbac India's existing poultry portfolio to the growing segment of avian vaccines.Founded in 2005, as a joint venture between Suguna Group, one of the leading Indian poultry conglomerates, and Lohmann Animal Health, a German poultry vaccines specialist, Globion has developed robust know-how and expertise in the...
Nasdaq GlobeNewswire
02/11/2023
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds…
PARIS and CAMBRIDGE, Mass., Nov.02, 2023(GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the pricing of its previously announced global follow-on offering reserved to specified categories of investors, consisting of (i) an offering of 3,106,907 American Depositary Shares (“ ADSs ”), each...
Nasdaq GlobeNewswire
02/11/2023
Digital Therapeutics Market is Anticipated to Reach USD 43.2 billion by 2031…
The increasing awareness of mental health issues and the demand for mental health support has driven the development of digital therapeutics for conditions like anxiety, depression, and stress management. The increasing awareness of mental health issues and the demand for mental health support has driven the development of digital therapeutics for conditions like anxiety, depression, and stress management. Healthcare providers and payers are increasingly incorporating digital therapeutics...
PR Newswire
02/11/2023
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH…
Presentations to highlight clinical utility of ZYNLONTA ®(loncastuximab tesirine-lpyl) as a single agent and in combination Oral presentation to include initial results of investigator-initiated Phase 2 study evaluating ZYNLONTA in combination with rituximab in patients with r/r follicular lymphoma LAUSANNE, Switzerland, Nov.02, 2023(GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced abstracts on ZYNLONTA ®(loncastuximab tesirine-lpyl) have been accepted for...
Nasdaq GlobeNewswire
02/11/2023
Nootropics Supplements Market to Reach $4.4 Billion, Globally, by 2032 at 6.3%…
Request Sample Report: https://www.alliedmarketresearch.com/request-sample/157136 Request Sample Report:https://www.alliedmarketresearch.com/request-sample/157136 Prime determinants of growth The growth of the global nootropics supplements market is majorly boosted by increased awareness of cognitive health, driven by stress, aging, and work pressures. Regulatory scrutiny has increased, which has fostered transparency and trust among consumers. Personalized nootropic solutions...
PR Newswire
02/11/2023
Furniture Village teams up with Dr Ranj to give top tips for beating tiredness…
Vitamin D has a role to play as it contributes to mood and energy levels. With less sun during the winter, you get less vitamin D which can make you feel more tired and, even a little down which could make you more likely to get ill. Vitamin D has a role to play as it contributes to mood and energy levels. With less sun during the winter, you get less vitamin D which can make you feel more tired and, even a little down which could make you more likely to get ill. Dr. Ranj has suggested a few...
PR Newswire
02/11/2023
Empatica's Platform Receives New FDA Clearance for Cardiac Digital Biomarkers
With the addition of pulse and respiratory rate, the Empatica Health Monitoring Platform now includes six FDA-cleared digital biomarkers, among the most offered for use in clinical trials. These are among the 128 digital measures supported by the platform, the largest offering available in a single solution, delivering confidence to a broad spectrum of health care professionals and researchers as they seek to validate treatments, better understand diseases, and innovate to improve health…
PR Newswire
02/11/2023
Mendus announces multiple abstracts to be presented at ASH 2023 including oral…
Press Release Stockholm, Sweden, November 2, 2023 Mendus announces multiple abstracts to be presented at ASH 2023 including oral presentation on ADVANCE II survival dataThree abstracts based on the ADVANCE II trial to be presented at ASH2023Relapse-free and overall survival data update to be presented as oral presentation on December 11Additional abstracts to be presented based on ADVANCE II immunomonitoring data Mendus AB (“Mendus” publ; IMMU.ST), a...
Nasdaq GlobeNewswire
02/11/2023
Dr. Kevin J. Tracey receives Hans Wigzell Research Foundation's Science Prize…
"The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases," said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation. "Dr. Tracey's research is a surprising new inroad to treat inflammation using computer chips targeting nerves instead of drugs." "The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop…
PR Newswire
02/11/2023
Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting…
Media Release COPENHAGEN, Denmark; November 2, 2023 Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populations Oral presentations highlighting new findings from a clinical trial of epcoritamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and a real-world analysis of patients with R/R large B-cell lymphoma (LBCL) will be...
Nasdaq GlobeNewswire
02/11/2023
Managers' Transaction
November 2, 2023 - Announcement No. 11 Vesting of restricted share unitsChr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Chr. Hansen Holding A/S made by persons discharging managerial responsibilities in Chr. Hansen Holding A/S and/or persons closely related with them.Please see attachment.For further information please contact: Anders Mohr Christensen, Vice President...
Nasdaq GlobeNewswire
02/11/2023
Theriva™ Biologics and Sant Joan de Déu-Barcelona Children's Hospital Advance…
- Theriva signs exclusive option to license intellectual property from Sant Joan de Déu-BarcelonaChildren's Hospital (SJD) to explore the therapeutic potential of VCN-01 in combination with topoisomerase I inhibitors - - Strengthens long-term research collaboration with SJD and builds on ongoing trial evaluating VCN-01 in pediatric cancers -- Emphasizes VCN-01's potential for use in diverse chemotherapy combinations and cancer indications - ROCKVILLE, Md. and BARCELONA, Spain, Nov...
Nasdaq GlobeNewswire
02/11/2023
Endo Launches Colchicine Capsules, Generic Version of MITIGARE®
Colchicine capsules are indicated for prophylaxis of gout flares in adults. Colchicine capsules are indicated for prophylaxis of gout flares in adults. According to IQVIA ™, colchicine capsules sales were approximately$65.4million for the 12 months endedSeptember 30, 2023. MITIGARE ®is a registered trademark of Hikma PharmaceuticalsUSA, Inc. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONSPatients with renal or hepatic impairment should not be given colchicine with...
PR Newswire
02/11/2023
COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business…
Highlights: COMP360 Phase 3 pivotal program ongoing with expanding European clinical sitesSecured up to $285 million private placement financing with $125 million upfrontCash position at September 30, 2023 of $248.0 millionConference call on November 2 at 8:00 am ET (12:00 pm UK)LONDON, Nov.02, 2023(GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...
Nasdaq GlobeNewswire
02/11/2023
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer's…
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer's Disease as a Surrogate of Clinical Efficacy on November 9, 2023Lausanne, Switzerland, November 02, 2023– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will host a KOL webinar on amyloid plaque PET imaging in Alzheimer's Disease as a surrogate of clinical efficacy on Thursday, November 9, 2023 at 10:00am...
Nasdaq GlobeNewswire
02/11/2023
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following…
Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers “The increasing complexity of clinical pharmacology studies demands fit-for-purpose infrastructure, experience and expertise to protect the safety of study participants and the integrity of critically important data,” said Oren Cohen, M.D., Fortrea's president of Clinical Pharmacology and chief medical officer. “Our...
Nasdaq GlobeNewswire
02/11/2023
European Medicines Agency validates Pierre Fabre Laboratories' marketing…
- If approved, the new indication for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) will be a potential new treatment option for adult patients with BRAFV600-mutant advanced NSCLC -If approved, the new indication for BRAFTOVI ®(encorafenib) + MEKTOVI ®(binimetinib) will be a potential new treatment option for adult patients with BRAF V600- mutant advanced NSCLC CASTRES,France , Nov. 2, 2023 /PRNewswire/ -- Intended for international media only / not intended for UK-...
PR Newswire
02/11/2023
Invitation to Immunovia's Q3 presentation
Telephone numbers and webcast Telephone numbers and webcast Call any of the numbers below to participate via telephone. Please dial in a few minutes before the presentation starts. Sweden : +46 (0)8 5051 0031 United Kingdom : +44 (0) 207 107 06 13 United States : +1 (1) 631 570 56 13 Link to the webcast: ...
PR Newswire
02/11/2023
Cambrex Announces Sale of Drug Product Business Unit
Cambrex recently expanded its portfolio of specialized solutions for pharmaceutical development and manufacturing with the acquisition of Snapdragon Chemistry, which specializes in R&D for API batch and continuous flow process development. Cambrex also recently acquired Q1 Scientific, a dedicated provider of outsourced stability storage services, including thermal cycling, disaster recovery, sample management, photostability and ultra-low storage. Q1 Scientific, based in Ireland, recently…
PR Newswire
02/11/2023
Philips and County Durham and Darlington NHS Foundation Trust collaborate on a…
Amsterdam, the Netherlands and Farnborough, UK – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and County Durham and Darlington NHS Foundation Trust (CDDFT), one of the largest integrated care providers in England, today announced the results of a comprehensive 360 sustainability analysis. The program identified key opportunities to reduce the carbon footprint and waste material within the intensive care unit (ICU) at Darlington Memorial Hospital....
Nasdaq GlobeNewswire
02/11/2023
RiverFort Global Capital Ltd is pleased to announce that it has arranged a…
Davinder Rai, CEO of Hellenic Dynamics, commented: Davinder Rai, CEO of Hellenic Dynamics, commented: "Having an institutional investor grant a 3-year facility of up toUS$3 millionto the Company for its next stage of expansion further to completion of phase 1 of its operations, allows the Company to move forward with its expansion plans. The splitting of the First Advance and the Second Advance provides capital optionality for the Company, and the granting of warrants at a 40%...
PR Newswire
02/11/2023
Mission Therapeutics to Present Abstract at American Society of Nephrology (ASN)…
Pau Aceves, MS, MSc, PharmD., Head of Clinical Pharmacology and Pharmacometrics, Mission Therapeutics, commented:We look forward to presenting our latest Phase 1 and Modelling & Simulation results on MTX652 for the treatment of acute kidney injury (AKI). The American Society of Nephrology is a major organization working toward a goal of a world without kidney diseases and we are excited to have the opportunity to share our progress at this important conference. Pau Aceves, MS, MSc, PharmD...
PR Newswire
02/11/2023
Altri Comunicati
